Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors
Added: 1 year ago Source:  Radcliffe Cardiology
AUTHOR: Jordan Rance; Special Editor: Greg GuilloryA new analysis sheds light on the timing of protection offered by SGLT2 inhibitors. Researchers conducted a cross-trial analysis using individual participant data from four large-scale randomized clinical trials: CANVAS (type 2 diabetes with high atherosclerotic risk, NCT01032629), CREDENCE (diabetic kidney disease, NCT02065791), DAPA-HF (heart… View more

Cardiovascular Kidney Metabolic

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care
Author(s): Javed Butler , Dinesh Khullar , John JV McMurray , et al Added: 4 months ago
In this expert-led webinar moderated by Dr Vijay Chopra, leading clinicians review current and emerging strategies in aldosterone modulation, hyperkalaemia management, and cardiorenal therapeutics.Dr Javed Butler opens with a practical overview of aldosterone’s central role in heart failure and CKD, emphasising the importance of achieving guideline-directed RAAS inhibitor and MRA dosing. He… View more

Prevention & Chronic Conditions

Heart Failure
Heart Rate Lowering Benefits are Context-Dependent, Meta-Analysis Finds
Added: 9 months ago Source:  Radcliffe Cardiology
AUTHOR: Jennifer ThomasThe long-standing debate over the benefits of heart rate (HR)-lowering drug treatment, particularly in patients with hypertension, has been addressed in a new large-scale meta-analysis. The findings, published in the European Heart Journal, suggest that the advantages of reducing HR are highly dependent on the patient's underlying clinical condition, with significant… View more

MI/ACS

Prevention & Chronic Conditions
EASD 24: FINEARTS-HF: Diabetes Status Analysis
Author(s): John JV McMurray Added: 1 year ago
EASD 24 - We are joined by Professor John McMurray (University of Glasgow, UK) to discuss the key findings from a diabetes subgroup analysis of the FINEARTS-HF study.Interview Questions:1. What is the reasoning behind this analysis?2. What was the study design and patient cohort?3. What are the key findings?4. In your opinion, what can explain this risk reduction?5. What are the take-home… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
ESC HF 25: The FIVE-STAR Trial
Author(s): Added: 11 months ago
ESC HF 25 - FIVE-STAR primary outcome is neutral, though finerenone was shown to significantly reduce UACR rates with a 29% greater reduction compared to placebo.We are joined by Dr Atsushi Tanaka (Saga University, Saga, JP) to discuss the findings from FIVE-STAR, a randomized trial investigating the effects of finerenone on vascular stiffness and cardiorenal biomarkers in patients with type 2… View more

Cardiovascular Kidney Metabolic
Lars Lund
Research Area(s) / Expertise: Job title: Associate Professor and Senior Consultant
Dr Lund's expertise is in HF big data and registry-based comparative outcomes studies and pragmatic trials. He is active in programs to improve utilisation of existing evidence-based interventions in heart failure with reduced ejection fraction, as well as in novel interventions. Dr Lars Lund is an Editorial Board member ofCardiac Failure Review. View more
Finn Gustafsson
Research Area(s) / Expertise: Job title: Professor of Cardiology
Finn Gustafsson, MD, PhD, DMSci, is a professor of cardiology at the University of Copenhagen and medical director of the advanced heart failure, transplantation and MCS program at Rigshospitalet in Copenhagen, Denmark. His clinical training in cardiology was conducted in Denmark and Canada. His research interests include several aspects of heart failure pathophysiology and management. He is an… View more
ESC 2025 Hot Line & Late-Breaking Collection
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 8 months ago
Dive into our coverage of ESC Congress 2025 for groundbreaking trial results and discussions with expert faculty.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen. Watch our Wrap-Upseries led byDr Mirvat Alasnag summarising the key take-aways from each day of the congress.For… View more

Imaging & Diagnostics

Intervention
Cecilia Linde
Job title: Professor and Head of Cardiology
Prof Cecilia Linde is a professor and consultant in cardiology at the Karolinska University Hospital in Stockholm, Sweden. Her research focuses on epidemiology and devices for use in heart failure. Her research currently focuses devices and their implementation and epidemiology in heart failure. Cecilia Linde is Vice President of the Board member of the ESC for the period of 2018-2020… View more
Obesity in the Asia-Pacific Region: Current Perspectives
Author(s): David Tak Wai Lui , Junya Ako , Jamshed Dalal , et al Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic